HOME >> BIOLOGY >> NEWS
Engineers discover why toucan beaks are models of lightweight strength

As a boy growing up in Brazil 40 years ago, Marc A. Meyers marveled at the lightweight toughness of toucan beaks that he occasionally found on the forest floor. Now a materials scientist and professor of mechanical and aerospace engineering at UCSD's Jacobs School of Engineering, Meyers said makers of airplanes and automobiles may benefit from the first ever detailed engineering analysis of toucan beaks conducted in his lab.

"Our computer modeling done shows that the beak is optimized to an amazing degree for high strength and very little weight," said Meyers. "It's almost as if the toucan has a deep knowledge of mechanical engineering."

In a paper to be published Dec. 1 in Acta Materialia, Meyers and graduate students Yasuaki Seki and Matthew S. Schneider reported that the secret to the toucan beak's lightweight strength is an unusual bio-composite. The interior of the beak is rigid "foam" made of bony fibers and drum-like membranes sandwiched between layers of keratin, the protein that makes up fingernails, hair, and horn. Just as the hook-shaped barbs on cockleburs inspired the development of Velcro, Meyers said the avian bio-composite could inspire the design of ultra-light aircraft and vehicle components with synthetic foams made with metals and polymers.

"The big surprise was our finding that the beak's sandwich structure also behaves as a high energy impact-absorption system," said Meyers. "Panels that mimic toucan beaks may offer better protection to motorists involved in crashes."

Toucans are highly social, noisy residents of rainforests in the Amazon, although the birds live as far north as Mexico. They use their extremely large and often brightly colored beaks for a variety of purposes, from gathering fruit from the tips of tree branches, to defending themselves.

Bird beaks are typically either short and thick or long and thin. The Meyers team decided to prospect for a novel material in toucan beaks because they are both
'"/>

Contact: Rex Graham
ragraham@ucsd.edu
858-822-3075
University of California - San Diego
30-Nov-2005


Page: 1 2

Related biology news :

1. Wiley extends publishing partnership with the American Institute of Chemical Engineers
2. Engineers develop process to recycle unused paint by blending it into common plastics
3. National panel led by LSU Chancellor releases report on Corps of Engineers
4. Top researcher-educators receive Presidential Early Career Award for Scientists and Engineers
5. Engineers create optoelectronic tweezers to round up cells, microparticles
6. Engineers improve plastics potential for use in implants by linking it to biological material
7. Wiley forms book publishing partnership with American Institute of Chemical Engineers
8. New, more direct pathways from outside the cell-to-cell nuclei discovered
9. deCODE discovers cause of major subtype of glaucoma
10. Weizmann Institute scientists discover a control mechanism for metastasis
11. Penn researchers discover how key protein stops inflammation

Post Your Comments:
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: